Melanoma (Skin) Stage IV Completed Phase 3 Trials for Teceleukin (DB15389)

Also known as: Stage 4 Melanoma / Melanoma Stage Iv / Stage IV Skin Melanoma / Stage IV Melanoma

IndicationStatusPhase
DBCOND0109891 (Melanoma (Skin) Stage IV)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00019682Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic MelanomaTreatment